<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01255943</url>
  </required_header>
  <id_info>
    <org_study_id>HHSA290200600013</org_study_id>
    <nct_id>NCT01255943</nct_id>
  </id_info>
  <brief_title>Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices</brief_title>
  <official_title>Testing Spread and Implementation of Novel MRSA-Reducing Practices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maine Medical Center Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agency for Healthcare Research and Quality (AHRQ)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Indiana University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maine Medical Center Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to implement strategies for improved efficiency and waste
      reduction (&quot;Toyota Lean&quot;) and positive deviance, a social behavioral change process,
      utilizing frontline healthcare personnel to reduce infection bloodstream infection and MRSA
      infection in outpatient dialysis care. In two outpatient dialysis units, dialysis unit
      healthcare staff will be educated in Toyota lean techniques and conduct periodic &quot;discovery
      and action&quot; dialogues to identify and implement care process changes to reduce infection.
      Outcomes to be monitored will include incidence of bloodstream infections and MRSA infections
      of all types. Data will be assessed at quarterly intervals using interrupted time series
      analysis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of bloodstream infections</measure>
    <time_frame>14 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of MRSA infections</measure>
    <time_frame>14 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">175</enrollment>
  <condition>Blood Stream Infections</condition>
  <condition>MRSA Infections</condition>
  <arm_group>
    <arm_group_label>prevalent hemodialysis patients</arm_group_label>
    <description>These patients are observed in two outpatient dialysis units with a combined census of approximately 175 patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>healthcare staff processes for infection prevention</intervention_name>
    <description>Toyota lean and positive deviance discovery and action dialogues to facilitate process improvement</description>
    <arm_group_label>prevalent hemodialysis patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        prevalent hemodialysis patients at two outpatient dialysis units
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: all hemodialysis patients at two outpatient dialysis units

        Exclusion Criteria:peritoneal dialysis patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark G Parker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maine Medical Center Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maine Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2010</study_first_submitted>
  <study_first_submitted_qc>December 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2010</study_first_posted>
  <last_update_submitted>March 28, 2017</last_update_submitted>
  <last_update_submitted_qc>March 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maine Medical Center Research Institute</investigator_affiliation>
    <investigator_full_name>Mark Parker</investigator_full_name>
    <investigator_title>Director, Division of Nephrology and Transplantation</investigator_title>
  </responsible_party>
  <keyword>MRSA</keyword>
  <keyword>bloodstream infections</keyword>
  <keyword>hemodialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

